HomeResearchThe Ubiquitin System and Cellular Regulation

Our Scientists

The Ubiquitin System and Cellular Regulation

Research Summary

Raymond Deshaies is investigating the cellular machinery that mediates protein degradation by the ubiquitin-proteasome system, and how this machinery regulates cell division.

Ubiquitin serves as a molecular tag that marks proteins for degradation (Figure 1). Ubiquitin is attached to proteins by a cascade of enzymes comprising ubiquitin-conjugating enzymes (E2s) and ubiquitin ligases (E3s). We investigate protein degradation via the ubiquitin-proteasome system (UPS) at multiple levels, including the regulatory circuitry that acts upstream of ubiquitin conjugation pathways that control cell division, the ubiquitin ligases that mediate attachment of ubiquitin to proteins, and the mechanism by which ubiquitin-modified proteins are brought to the proteasome and degraded. We seek to discover new components of the UPS and uncover basic knowledge about how components of the UPS work, how their activities are regulated, what their substrates are, and how they contribute to cellular regulation. We also seek to develop drugs that target UPS enzymes for use as research tools. Given that defects in the UPS lead to cancer, neurodegenerative diseases, and autoimmune disease, we anticipate that a better understanding of the UPS will provide insight into diseases that afflict millions of people. We hope that this insight leads to novel therapies.

SCF and the Superfamily of Cullin-RING Ubiquitin Ligases
Our work to understand the biochemical mechanism by which yeast cells enter into the S phase of the cell division program where they duplicate their chromosomes led us to discover the SCFCdc4 ubiquitin ligase, one of whose jobs is to attach ubiquitin to a protein known as Sic1 (Figure 2). Sic1 restrains chromosome duplication by binding to and inhibiting the S-phase–promoting cyclin-dependent kinase. Immediately prior to S phase, SCFCdc4 binds Sic1 and attaches ubiquitin to it. An enzyme complex known as the 26S proteasome then degrades ubiquitin-modified Sic1. In this manner, active cyclin-dependent kinase is released from Sic1, so that it can promote chromosome duplication.

Although SCFCdc4 was discovered as a regulator of chromosome duplication in yeast, we now appreciate that it is the archetype of a superfamily of ubiquitin ligase enzymes that share a similar modular architecture. At the core of this superfamily is a module composed of a cullin subunit and a RING subunit, and hence these enzymes are referred to as cullin-RING ligases (CRLs). The cullin-RING module recruits both an E2 enzyme via the RING subunit and a substrate-binding module. This brings substrate and E2 enzyme into proximity to enable substrate ubiquitination (Figure 3).

There are nine cullin-related proteins in humans. The Cul1 subunit that underlies SCF ubiquitin ligases binds the linker protein Skp1. Skp1, in turn, binds the F-box domain of a substrate receptor protein. There are 69 F-box proteins in human cells, and thus potentially as many as 69 distinct SCF ubiquitin ligase complexes, each with a different substrate specificity. Each cullin uses a different linker protein to recruit a different family of substrate receptors. All told, there may be up to 240 CRLs in human cells. These enzymes control processes as diverse as circadian rhythms, the innate immune response, and glucose sensing. Given their key role in numerous regulatory pathways, we seek to understand how CRLs work, how they are regulated, what their substrates are, and how they are deployed in regulatory circuits to control processes such as gene transcription and cell division.

How CRLs Work
Despite their pivotal role in numerous regulatory pathways, we are only beginning to understand how CRLs work. Degradation of CRL substrates such as Sic1 is sustained by assembling upon the substrate a chain of ubiquitins linked together via their lysine-48 residues. We seek to understand how SCF and other CRLs work by using chemical biology approaches to develop novel substrates and tools, by devising new assays based on stop-flow and quench-flow techniques to measure real-time dynamics of enzyme-substrate complexes and ubiquitin ligation with millisecond time resolution, and by developing structural and mathematical models to help us understand how the assembly of a ubiquitin chain proceeds.

Regulation of CRLs by the Ubiquitin-like Protein Nedd8
Because of the broad role that human SCF and other CRL enzymes play, we sought to identify proteins that control SCF activity. This led us to discover that COP9 signalosome (CSN) is a key regulator of all CRLs. CSN detaches a ubiquitin-like protein, Nedd8, from the cullin subunit of CRLs. This reaction is catalyzed by the Csn5 subunit, which together with the related Rpn11 subunit of the proteasome defined a new family of JAMM (Jab1/MPN-domain metalloenzyme) metalloproteases. CSN was previously implicated in multiple developmental processes, including photomorphogenesis in plants, neuronal differentiation, and axon guidance. Our observations suggest that the diverse activities of CSN may arise from its ability to control CRLs and other Nedd8-modified proteins.

Unexpectedly, both attachment of Nedd8 to cullins and its subsequent removal by CSN stimulate CRL activity, suggesting that active CRLs are sustained by a continuous cycle of Nedd8 attachment and removal (Figure 4). How this cycle operates, how it controls CRL activity, and how it is regulated remain unsolved mysteries. We seek to address these questions by applying enzymological approaches, chemical biology, and quantitative proteomics to devise new assays and tools to study CSN and the cycle of cullin neddylation and deneddylation both in vitro and in cells.

How CRL Substrates Are Delivered to the Proteasome and Degraded
A recent topic of interest to us concerns the role of the AAA ATPase Cdc48/p97 in the UPS. Some proteasome substrates require p97 to be degraded, but the mechanism by which p97 works remains obscure. Adding to the mystery is the fact that there are more than a dozen different p97 complexes in human cells. We believe that these complexes act at the proteasome to help unfold substrates as a prelude to their degradation. However, we don't really know how p97 is doing this, nor do we understand why so many different Ubxd-p97 complexes exist, and how their activities relate to ubiquitin receptor proteins that guide substrates to the proteasome.

Recently, we have found through proteomic studies that p97 assembles with a broad range of CRLs through the agency of the adaptor protein Ubxd7, suggesting that p97 plays an intimate role in the numerous regulatory processes governed by this family of ubiquitin ligases. We seek to understand how Ubxd7-p97 activity is targeted to CRLs. We also seek to identify selective and potent small-molecule inhibitors of p97 ATPase activity that can be used as tools to study the connection between p97 and CRLs. We will continue to use chemical biology, proteomic, genetic, and biochemical reconstitution approaches to investigate the role of yeast and human p97 in degradation of CRL substrates.

Proteomics
The human ubiquitin system comprises hundreds of different enzymes, including ~570 ubiquitin ligases, ~40 E2s, ~95 deubiquitinating enzymes, and about a dozen each of ubiquitin chain receptors and Cdc48/p97 complexes. Collectively, these factors target thousands of human proteins for degradation. One of the most intractable problems in the ubiquitin field is the identification of the proteins that are targeted for degradation by any one component of the UPS. To identify the proteins whose ubiquitination is altered in cells that are lacking individual components of the UPS, we are using a powerful mass spectrometry–based approach that enables the identification and quantification of ubiquitin-conjugated proteins in total cell extract (Figure 5). We are also using quantitative mass spectrometry methods to catalog the network of CRLs and how it changes in response to chemical and genetic perturbations.

Regulation of the Exit from Mitosis
As with the entry into S phase, the exit from mitosis/cell division is triggered by ubiquitin-dependent degradation (Figure 1). The mitosis phase of the cell cycle program requires an enzyme known as mitotic cyclin–dependent kinase. As long as mitotic cyclin–dependent kinase is on, the cell is in mitosis. At the end of mitosis, the mitotic cyclin is degraded, which shuts off the associated kinase activity, allowing the cell to exit mitosis. The protein phosphatase Cdc14 is required to switch on mitotic cyclin destruction. For most of the cell cycle program, Cdc14 is sequestered in an inactive state within the cell nucleolus by the nucleolar protein Net1. At the end of mitosis, Cdc14 is released from Net1 and spreads throughout the nucleus and cytoplasm (Figure 6). The freed Cdc14 switches on anaphase-promoting complex/cyclosome (APC) ubiquitin ligase by dephosphorylating its regulator Hct1/Cdh1. Active APC attaches ubiquitin to mitotic cyclin, triggering its degradation. We are investigating the signals that govern Cdc14's release from the nucleolus and dispersal throughout the cell (Figure 7). Most recently, we showed that a nuclear localization sequence in Cdc14 is directly phosphorylated in late mitosis, which promotes its redistribution to the cytoplasm, where it can dephosphorylate and activate Hct1/Cdh1.

Grants from the National Institutes of Health provide support for the work on CSN and on mitotic exit.

As of May 30, 2012

Scientist Profile

Investigator
California Institute of Technology
Biochemistry, Cell Biology